Files and links (1)
Published, Version of Record (VoR)CC BY V4.0, Open
Journal article
Euglycemic ketoacidosis following a single dose of empagliflozin
Toxicology communications, v 1(1), pp 18-20
01 Jan 2017
Abstract
Sodium-glucose co-transporter 2 (SGLT-2) inhibitors have recently joined the therapeutic armamentarium for the treatment of diabetes mellitus. SGLT-2 inhibitors, as monotherapy or in combination with other medications, have a favorable effect on hemoglobin A1C concentrations. However, a growing number of reports have described ketoacidosis as a complication following prolonged SGLT-2 inhibitor therapy. We report a case of SGLT-2 inhibitor associated ketoacidosis in a patient following a single first dose of empagliflozin.
Metrics
9 Record Views
Details
- Title
- Euglycemic ketoacidosis following a single dose of empagliflozin
- Creators
- Muhammad Masood Khalid - Drexel UniversityDavid J. Vearrier - Drexel UniversityMichael I. Greenberg - Drexel University
- Publication Details
- Toxicology communications, v 1(1), pp 18-20
- Publisher
- Taylor & Francis
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine; Emergency Medicine
- Other Identifier
- 991019312607904721